MSB 7.69% $1.19 mesoblast limited

Ryoncil: ODAC/FDA Meeting Discussion, page-13

  1. 7,518 Posts.
    lightbulb Created with Sketch. 6772
    Personally, bar perhaps the statistician, I see an overwhelming vote for. Perhaps I've confirmation bias, but I just see those slides as comprehensively addressing the issues raised and basically closing out most arguments against endorsing Ryconcil.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.